Blaise Genton

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


339 publications

... | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1990 | 1989 | 1988 |
 
Rechauffement climatique et malaria: un debat chaud. [Global warming and malaria: a hot debate]
Genton B., Loutan L., 2007/05. Revue Médicale Suisse, 3 (111) pp. 1219-20.
 
Sites internet dedies a la malaria. [Malaria websites]
Genton B., 2007/05. Revue Médicale Suisse, 3 (111) pp. 1249-52.
 
Vaccination contre la fievre jaune. [Immunization against yellow fever]
Landry P., Genton B., 2007/05. Revue Médicale Suisse, 3 (111) pp. 1237-40.
Severe dengue virus infection in travelers: risk factors and laboratory indicators
Wichmann O., Gascon J., Schunk M., Puente S., Siikamaki H., Gjorup I., Lopez-Velez R., Clerinx J., Peyerl-Hoffmann G., Sundoy A. et al., 2007/04. Journal of Infectious Diseases, 195 (8) pp. 1089-96.
 
The sensitivity of the OptiMAL rapid diagnostic test to the presence of Plasmodium falciparum gametocytes compromises its ability to monitor treatment outcomes in an area of Papua New Guinea in which malaria is endemic
Mueller I., Betuela I., Ginny M., Reeder J. C., Genton B., 2007/02. Journal of Clinical Microbiology, 45 (2) pp. 627-30.
A randomized placebo-controlled phase Ia malaria vaccine trial of two virosome-formulated synthetic peptides in healthy adult volunteers.
Genton B., Pluschke G., Degen L., Kammer A.R., Westerfeld N., Okitsu S.L., Schroller S., Vounatsou P., Mueller M.M., Tanner M. et al., 2007. PLoS ONE, 2 (10) pp. e1018. Peer-reviewed.
 
A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial.
Okitsu S.L., Silvie O., Westerfeld N., Curcic M., Kammer A.R., Mueller M.S., Sauerwein R.W., Robinson J.A., Genton B., Mazier D. et al., 2007. Plos One, 2 (12) pp. e1278.
 
Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversity
Fluck C., Schopflin S., Smith T., Genton B., Alpers M. P., Beck H. P., Felger I., 2007/01. Infection, Genetics and Evolution, 7 (1) pp. 44-51.
Evidence of efficacy is not enough to develop recommendations: antibiotics for treatment of traveler's diarrhea.
Genton B., D'Acremont V., 2007. Clinical Infectious Diseases, 44 (11) pp. 1520-1522.
 
Incidence and types of illness when traveling to the tropics: a prospective controlled study of children and their parents.
Newman-Klee C., D'Acremont V., Newman C.J., Gehri M., Genton B., 2007. American Journal of Tropical Medicine and Hygiene, 77 (4) pp. 764-769. Peer-reviewed.
 
Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J., Müeller I., Sie A., Maku P., Goroti M., Reeder J.C., Beck H.P., Genton B., 2007. American Journal of Tropical Medicine and Hygiene, 77 (5) pp. 947-954.
 
Malaria chemoprophylaxis: what do the travelers choose, and how does pretravel consultation influence their final decision.
Senn N., D'Acremont V., Landry P., Genton B., 2007. American Journal of Tropical Medicine and Hygiene, 77 (6) pp. 1010-1014.
 
Malaria: nouvelles stratégies de traitement
Genton B., D'Acremont V., 2007. Swiss Medical Forum = Forum Médical Suisse, 7 (17) pp. 386-392.
Medical care of asylum seekers: a descriptive study of the appropriateness of nurse practitioners' care compared to traditional physician-based care in a gatekeeping system.
Bodenmann P., Althaus F., Burnand B., Vaucher P., Pécoud A., Genton B., 2007. BMC Public Health, 7 pp. art. 310 [10 p.]. Peer-reviewed.
 
Stop ambiguous messages on malaria diagnosis.
D'Acremont V., Lengeler C., Genton B., 2007. Bmj (Clinical Research Ed.), 334 (7592) p. 489. Peer-reviewed.
 
www.fevertravel.ch: an online study prototype to evaluate the safety and feasibility of computerized guidelines for fever in returning travellers and migrants
Ambresin Anne-Emmanuelle, D'Acremont Valérie, Mueller Yolanda, Martin O., Burnand Bernard, Genton Blaise, 2007. Computer Methods and Programs in Biomedicine, 85 (1) pp. 19-31. Peer-reviewed.
 
Chikungunya: an epidemic in real time
Bodenmann P., Genton B., 2006/07. Lancet, 368 (9531) p. 258. Peer-reviewed.
 
Voyages, globalisation et acces a la sante. [Travel, globalization and access to health care]
Loutan L., Genton B., 2006/05. Revue Médicale Suisse, 2 (65) pp. 1219-20.
 
Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine
Rendi-Wagner P., Shouval D., Genton B., Lurie Y., Rumke H., Boland G., Cerny A., Heim M., Bach D., Schroeder M. et al., 2006/04. Vaccine, 24 (15) pp. 2781-9.
 
Urban malaria in the Sahel: prevalence and seasonality of presumptive malaria and parasitaemia at primary care level in Chad
Othnigue N., Wyss K., Tanner M., Genton B., 2006/02. Tropical Medicine and International Health, 11 (2) pp. 204-10.
 
Diarrhée des voyageurs: résistance aux antibiotiques [Travelers' diarrhea: resistance to antibiotics].
Genton B., D'Acremont V., 2006. Revue Médicale Suisse, 2 (65) pp. 1224-1230.
 
Do travelers really take their mefloquine malaria chemoprophylaxis? Estimation of adherence by an electronic pillbox.
Landry P., Iorillo D., Darioli R., Burnier M., Genton B., 2006. Journal of Travel Medicine, 13 (1) pp. 8-14. Peer-reviewed.
 
Hepatitis A vaccines and the elderly.
Genton B., D'Acremont V., Furrer H.J., Hatz C., Loutan L., 2006. Travel Medicine and Infectious Disease, 4 (6) pp. 303-312.
 
Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.
D'Acremont V., Herzog C., Genton B., 2006. Journal of Travel Medicine, 13 (2) pp. 78-83.
 
Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania
Mugittu K., Genton B., Mshinda H., Beck H. P., 2006. Malaria Journal, 5 p. 126.
Rifampicin/Cotrimoxazole/Isoniazid versus mefloquine or quinine + sulfadoxine- pyrimethamine for malaria: a randomized trial.
Genton B., Mueller I., Betuela I., Casey G., Ginny M., Alpers M.P., Reeder J.C., 2006. PLoS Clinical Trials, 1 (8) pp. e38. Peer-reviewed.
 
Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea
Genton B., Baea K., Lorry K., Ginny M., Wines B., Alpers M. P., 2005/12. Papua New Guinea Medical Journal, 48 (3-4) pp. 141-50.
 
Le diagnostic de malaria au cabinet: comment gérer t'incertitude [Diagnosis of malaria in general practice: dealing with uncertainty].
Genton B., D'Acremont V., 2005/05. Revue Médicale Suisse, 1 (19) pp. 1284-1289.
 
Le don, un "Basic instinct"... ? [Donating, a basic instinct?]
Genton B., Loutan L., 2005/05. Revue Médicale Suisse, 1 (19) pp. 1251-2.
 
Meta-analysis: accuracy of rapid tests for malaria in travelers returning from endemic areas
Marx A., Pewsner D., Egger M., Nuesch R., Bucher H. C., Genton B., Hatz C., Juni P., 2005/05. Annals of Internal Medicine, 142 (10) pp. 836-46.
 
Prophytaxie pre- et postexpositionnelle de la rage: qui vacciner et comment? [Pre- and post-exposure rabies prophylaxis: who to vaccinate and how?]
Senn N., Genton B., 2005/05. Revue Médicale Suisse, 1 (19) pp. 1280-3.
 
VIH et voyage [HIV and travel].
D'Acremont V., Cavassini M.L., Tarr P.E., Genton B., 2005/05. Revue Médicale Suisse, 1 (19) pp. 1268-1274.
 
Cutaneous leishmaniasis caused by Leishmania tropica: treatment with oral fluconazole
Laffitte E., Genton B., Panizzon R. G., 2005. Dermatology, 210 (3) pp. 249-51.
 
Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies
Mugittu K., Abdulla S., Falk N., Masanja H., Felger I., Mshinda H., Beck H. P., Genton B., 2005. Malaria Journal, 4 (1) p. 55.
How critical is timing for the diagnosis of influenza in general practice?
Senn N., Favrat B., D'Acremont V., Ruffieux C., Genton B., 2005. Swiss Medical Weekly, 135 (41-42) pp. 614-617. Peer-reviewed.
 
Pharmacotherapy, vaccines and malaria advice for HIV-infected travellers.
Cavassini M.L., D'Acremont V., Furrer H., Genton B., Tarr P.E., 2005. Expert Opinion on Pharmacotherapy, 6 (6) pp. 891-913.
 
Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04
Boland G., Beran J., Lievens M., Sasadeusz J., Dentico P., Nothdurft H., Zuckerman J. N., Genton B., Steffen R., Loutan L. et al., 2004/12. Vaccine, 23 (3) pp. 316-20.
 
Strain-specific humoral response to a polymorphic malaria vaccine
Fluck C., Smith T., Beck H. P., Irion A., Betuela I., Alpers M. P., Anders R., Saul A., Genton B., Felger I., 2004/11. Infection and Immunity, 72 (11) pp. 6300-5.
 
Médecine géographique pour le praticien
Genton B., Jacquérioz F.A., D' Acremont V., 2004/04. 124, Médecine et Hygiène.
 
Molecular analysis of Plasmodium falciparum from drug treatment failure patients in Papua New Guinea
Casey G. J., Ginny M., Uranoli M., Mueller I., Reeder J. C., Genton B., Cowman A. F., 2004/03. American Journal of Tropical Medicine and Hygiène, 70 (3) pp. 251-5.
Intranasal versus injectable influenza vaccine.
Genton B., D'Acremont V., 2004. Clinical Infectious Diseases, 39 (5) pp. 754-755.
 
Qu'en est-île des risques?
D'Acremont V., Genton B., 2004. Médecine et Hygiène, 62 (2482) pp. 1015-1021.
 
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children
Genton B., Al-Yaman F., Betuela I., Anders R. F., Saul A., Baea K., Mellombo M., Taraika J., Brown G. V., Pye D. et al., 2003/12. Vaccine, 22 (1) pp. 30-41.
 
The malaria vaccine development program in Papua New Guinea
Genton B., Anders R. F., Alpers M. P., Reeder J. C., 2003/06. Trends in Parasitology, 19 (6) pp. 264-70.
 
Molecular monitoring in malaria vaccine trials
Felger I., Genton B., Smith T., Tanner M., Beck H. P., 2003/02. Trends in Parasitology, 19 (2) pp. 60-3.
Das Kind auf (Fern)-Reise. Empfehlungen für die ärztliche Beratung und medizinische Vorbereitung (Teil 1)
Gehri M., D'Acremont V., Genton B., 2003. Pädiatrie 3 pp. 4-8.
Das Kind auf (Fern)-Reise. Empfehlungen für die ärztliche Beratung und medizinische Vorbereitung (Teil 2)
Gehri M., D'Acremont V., Genton B., 2003. Pädiatrie 2 pp. 1-4.
 
Fièvre au retour de voyage: où, quand? [Investigating fever after travel].
D'Acremont V., Jaquérioz F., Genton B., 2003. Revue Médicale de la Suisse Romande, 123 (2) pp. 89-92.
 
Practice guidelines for evaluation of Fever in returning travelers and migrants.
D'Acremont V., Ambresin A.E., Burnand B., Genton B., Travel clinic Medical Outpatient Clinic University of Lausanne Rue Bugnon 44 1011 Lausanne Switzerland, 2003. Journal of Travel Medicine, 10 (Suppl. 2) pp. S25-S52. Peer-reviewed.
Prevalence rate and reasons for refusals of influenza vaccine in elderly.
Canova L., Birchmeier M., D'Acremont V., Abetel G., Favrat B., Landry P., Mancini M., Verdon F., Pécoud A., Genton B., 2003. Swiss Medical Weekly, 133 (43-44) pp. 598-602. Peer-reviewed.
Préparer l'enfant voyageur. Recommendations pour des voyages hors d'Europe (partie 1)
Gehri M., D'Acremont V., Genton B., 2003. Pädiatrie 3 pp. 16-20.
Préparer l'enfant voyageur. Recommendations pour des voyages hors d'Europe (partie 2)
Gehri M., D'Acremont V., Genton B., 2003. Pädiatrie 2 pp. 1-4.
 
SARS ? semble à une e-pidémie
Genton B., Loutan L., 2003. Médecine et Hygiène, 61 pp. 1003-1004.
 
Vaccination chez les migrants
Genton B., D'Acremont V., Desgrandchamps D., 2003. Médecine et Hygiène, 61 (2455) pp. 2045-2048.
 
www.fevertravel.ch : site internet de recommandations pour la pratique clinique concernant l'évaluation de la fièvre chez les voyageurs et migrants [www.fevertravel.ch: a website for the evaluation and management returning travelers or migrants with fever]
D'Acremont V., Ambresin A.E., Pittet V., Burnand B., Genton B., 2003. Médecine et Hygiène, 61 (2437) pp. 1022-1026.
 
Vaccins contre la pauvrete. [Vaccines against poverty]
Genton B., 2002/12. Revue Médicale de la Suisse Romande, 122 (12) pp. 581-4.
 
Malaria vaccines: from the laboratory to the field.
Genton B., Corradin G., 2002/10. Current Drug Targets. Immune, Endocrine and Metabolic Disorders, 2 (3) pp. 255-267.
 
Malaria.02: la recherche pour une exposition mondiale. [Malaria.02: research for a world-wide exposition]
Genton B., D'Acremont V., 2002/10. Revue Médicale de la Suisse Romande, 122 (10) pp. 479-84.
Clinical and laboratory predictors of imported malaria in an outpatient setting: an aid to medical decision making in returning travellers with fever
D'Acremont V., Landry P., Mueller I., Pécoud A., Genton B., 2002/05. American Journal of Tropical Medicine and Hygiene.
 
Clonal groupings in serogroup X Neisseria meningitidis
Gagneux S., Wirth T., Hodgson A., Ehrhard I., Morelli G., Kriz P., Genton B., Smith T., Binka F., Pluschke G. et al., 2002/05. Emerging Infectious Diseases, 8 (5) pp. 462-6.
 
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea
Genton B., Betuela I., Felger I., Al-Yaman F., Anders R. F., Saul A., Rare L., Baisor M., Lorry K., Brown G. V. et al., 2002/03. Journal of Infectious Diseases, 185 (6) pp. 820-7.
 
Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana
Gagneux S. P., Hodgson A., Smith T. A., Wirth T., Ehrhard I., Morelli G., Genton B., Binka F. N., Achtman M., Pluschke G., 2002/03. Journal of Infectious Diseases, 185 (5) pp. 618-26.
 
Mosquito nets for the elderly?
Smith T., Genton B., Betuela I., Rare L., Alpers M. P., 2002/02. Transactions of the Royal Society of Tropical Medicine and Hygiène, 96 (1) pp. 37-8.
 
Improving influenza vaccination rates in the elderly.
Birchmeier M., Favrat B., Pécoud A., Abetel G., Karly M., Landry P., Mancini M., Verdon F., Genton B., 2002. Journal of Family Practice, 51 (10) p. 856. Peer-reviewed.
 
Recommandations cliniques pour l'évaluation de la fièvre chez les voyageurs ou migrants
D'Acremont V., Burnand B., Genton B., 2002. Médecine et Hygiène, 60 (No Spécial) pp. S21-S23.
 
Treatment of imported malaria in an ambulatory setting: prospective study.
D'Acremont V., Landry P., Darioli R., Stuerchler D., Pécoud A., Genton B., 2002. Bmj (Clinical Research Ed.), 324 (7342) pp. 875-877.
 
Survival and sequelae of meningococcal meningitis in Ghana
Hodgson A., Smith T., Gagneux S., Akumah I., Adjuik M., Pluschke G., Binka F., Genton B., 2001/12. International Journal of Epidemiology, 30 (6) pp. 1440-6.
 
Risk factors for meningococcal meningitis in northern Ghana
Hodgson A., Smith T., Gagneux S., Adjuik M., Pluschke G., Mensah N. K., Binka F., Genton B., 2001/10. Transactions of the Royal Society of Tropical Medicine and Hygiène, 95 (5) pp. 477-80.
 
Malaria-Chemoprophylaxe 2001. [Malaria--chemoprophylaxis 2001]
Hatz F. R., Beck B., Blum J., Funk M., Furrer H., Genton B., Holzer B., Loutan L., Markwalder K., Raeber P. A. et al., 2001/06. Therapeutische Umschau, 58 (6) pp. 347-51.
 
Prolonged visual illusions induced by mefloquine (Lariam): a case report
Borruat F. X., Nater B., Robyn L., Genton B., 2001/06. Journal of Travel Medicine, 8 (3) pp. 148-9.
 
Prospective risk of morbidity in relation to malaria infection in an area of high endemicity of multiple species of Plasmodium
Smith T., Genton B., Baea K., Gibson N., Narara A., Alpers M. P., 2001/06. American Journal of Tropical Medicine and Hygiène, 64 (5-6) pp. 262-7.
 
Absence of anti-hepatitis B surface antibody after vaccination does not necessarily mean absence of immune response.
Greub G., Zysset F., Genton B., Spertini F., Frei P.C., 2001/04. Medical Microbiology and Immunology, 189 (3) pp. 165-168. Peer-reviewed.
 
Associations of peak shifts in age--prevalence for human malarias with bednet coverage
Smith T., Hii J. L., Genton B., Muller I., Booth M., Gibson N., Narara A., Alpers M. P., 2001/02. Transactions of the Royal Society of Tropical Medicine and Hygiène, 95 (1) pp. 1-6.
 
Clinical features of malaria in returning travelers and migrants
Genton B., D'Acremont V., 2001. pp. 371-392 dans Schlagenhauf-Lawlor P. (eds.) Travelers' Malaria, BC Decker.
 
Compliance to live oral Ty21a typhoid vaccine, and its effect on viability.
Stubi C.L., Landry P.R., Pétignat C., Bille J., Genton B., Darioli R., Burnier M., 2001. Journal of Travel Medicine, 7 (3) pp. 133-137. Peer-reviewed.
 
L'enfant voyageur
Genton B., D'Acremont V., Gehri M., 2001. Médecine et Hygiène, 59 (2348) pp. 1186-1191.
 
Comparison of the reactogenicity and immunogenicity of a two injection combined high-dose hepatitis A and hepatitis B vaccine to those of Twinrix
Greub G., Genton B., Safary A., Thoelen S., Frei P. C., 2000/12. Vaccine, 19 (9-10) pp. 1113-7.
 
The epidemiology and control of lymphatic filariasis on Lihir Island, New Ireland Province
Hii J., Bockarie M. J., Flew S., Genton B., Tali A., Dagoro H., Waulas B., Samson M., Alpers M. P., 2000/12. Papua New Guinea Medical Journal, 43 (3-4) pp. 188-95.
 
Assessment of different sources of variation in the antibody responses to specific malaria antigens in children in Papua New Guinea
Stirnadel H. A., Al-Yaman F., Genton B., Alpers M. P., Smith T. A., 2000/06. International Journal of Epidemiology, 29 (3) pp. 579-86.
 
The influence of zinc supplementation on morbidity due to Plasmodium falciparum: a randomized trial in preschool children in Papua New Guinea
Shankar A. H., Genton B., Baisor M., Paino J., Tamja S., Adiguma T., Wu L., Rare L., Bannon D., Tielsch J. M. et al., 2000/06. American Journal of Tropical Medicine and Hygiène, 62 (6) pp. 663-9.
 
Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea
Genton B., Al-Yaman F., Anders R., Saul A., Brown G., Pye D., Irving D. O., Briggs W. R., Mai A., Ginny M. et al., 2000/05. Vaccine, 18 (23) pp. 2504-11.
 
Microheterogeneity of serogroup A (subgroup III) Neisseria meningitidis during an outbreak in northern Ghana
Gagneux S., Hodgson A., Ehrhard I., Morelli G., Genton B., Smith T., Tanner M., Binka F., Achtman M., Pluschke G., 2000/04. Tropical Medicine and International Health, 5 (4) pp. 280-7.
 
Inactivated hepatitis A vaccine booster given >/=24 months after the primary dose.
Landry P., Tremblay S., Darioli R., Genton B., 2000. Vaccine, 19 (4-5) pp. 399-402. Peer-reviewed.
 
Malaria sévère : multitude d'études mais peu de certitudes
Genton B., D'Acremont V., 2000. Médecine et Hygiène, 58 (2301) pp. 1105-1111.
 
Rapid diagnostics tests for malaria in returning travellers
Genton B., D'Acremont V., 2000. British Medical Journal pp. 31 August 2000.
 
Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea
Zimmerman P. A., Woolley I., Masinde G. L., Miller S. M., McNamara D. T., Hazlett F., Mgone C. S., Alpers M. P., Genton B., Boatin B. A. et al., 1999/11. Proceedings of the National Academy of Sciences of the United States of America, 96 (24) pp. 13973-7.
 
Effect of vitamin A supplementation on morbidity due to Plasmodium falciparum in young children in Papua New Guinea: a randomised trial
Shankar A. H., Genton B., Semba R. D., Baisor M., Paino J., Tamja S., Adiguma T., Wu L., Rare L., Tielsch J. M. et al., 1999/07. Lancet, 354 (9174) pp. 203-9.
 
Routine screening of children returning home from the tropics. Authors' definition of asymptomatic children is not the one usually accepted
Genton B., Gehri M., 1999/07. BMJ, 319 (7202) pp. 121; author reply 122. Peer-reviewed.
 
The effect of distance from home on attendance at a small rural health centre in Papua New Guinea
Muller I., Smith T., Mellor S., Rare L., Genton B., 1998/10. International Journal of Epidemiology, 27 (5) pp. 878-84.
 
Relation of anthropometry to malaria morbidity and immunity in Papua New Guinean children
Genton B., Al-Yaman F., Ginny M., Taraika J., Alpers M. P., 1998/09. American Journal of Clinical Nutrition, 68 (3) pp. 734-41.
 
The ratio of reactive nitrogen intermediates to tumour necrosis factor and clinical outcome of falciparum malaria disease
al-Yaman F. M., Genton B., Clark I. A., 1998/08. Transactions of the Royal Society of Tropical Medicine and Hygiène, 92 (4) pp. 417-20.
 
The correlation between microscopical examination and erythrocyte band 3 (AE1) gene deletion in South-east Asian ovalocytosis
Mgone C. S., Genton B., Peter W., Paniu M. M., Alpers M. P., 1998/06. Transactions of the Royal Society of Tropical Medicine and Hygiène, 92 (3) pp. 296-9.
 
Quels vaccins pour les voyageurs? [Which vaccines for the traveler?]
Loutan L., Genton B., 1998/04. Revue Médicale de la Suisse Romande, 118 (4) pp. 329-34.
 
Vaccinations de routine chez l'adulte ou comment proteger les extremes de la vie? [Routine vaccinations in adults or how to protect each stage of life?]
Genton B., Loutan L., 1998/04. Revue Médicale de la Suisse Romande, 118 (4) pp. 319-28.
 
Diagnosis of Plasmodium falciparum infection using ParaSight(R)-F test in blood and urine of Papua New Guinean children
Genton B., Paget S., Beck H. P., Gibson N., Alpers M. P., Hii J., 1998/03. Southeast Asian Journal of Tropical Medicine and Public Health, 29 (1) pp. 35-40.
 
Naturally acquired cellular immune responses to the synthetic malarial peptide SPf66 in children in Papua New Guinea
al-Yaman F., Genton B., Taraika J., Alpers M. P., 1997/12. Transactions of the Royal Society of Tropical Medicine and Hygiène, 91 (6) pp. 709-12.
 
T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic
Connelly M., King C. L., Bucci K., Walters S., Genton B., Alpers M. P., Hollingdale M., Kazura J. W., 1997/12. Infection and Immunity, 65 (12) pp. 5082-7.
 
Reduced risk of clinical malaria in children infected with multiple clones of Plasmodium falciparum in a highly endemic area: a prospective community study
al-Yaman F., Genton B., Reeder J. C., Anders R. F., Smith T., Alpers M. P., 1997/10. Transactions of the Royal Society of Tropical Medicine and Hygiène, 91 (5) pp. 602-5.
 
Association between cellular response (IL-4) to RESA/Pf155 and protection from clinical malaria among Papua New Guinean children living in a malaria endemic area
al-Yaman F., Genton B., Taraika J., Anders R., Alpers M. P., 1997/06. Parasite Immunology, 19 (6) pp. 249-54.
 
Indicators of fatal outcome in paediatric cerebral malaria: a study of 134 comatose Papua New Guinean children
Genton B., al-Yaman F., Alpers M. P., Mokela D., 1997/06. International Journal of Epidemiology, 26 (3) pp. 670-6.
 
PCR amplification of DNA from malaria parasites on fixed and stained thick and thin blood films
Edoh D., Steiger S., Genton B., Beck H. P., 1997/06. Transactions of the Royal Society of Tropical Medicine and Hygiène, 91 (3) pp. 361-3.
 
Cellular immunity to merozoite surface protein 2 (FC27 and 3D7) in Papua New Guinean children. Temporal variation and relation to clinical and parasitological status
al-Yaman F., Genton B., Taraika J., Anders R., Alpers M. P., 1997/05. Parasite Immunology, 19 (5) pp. 207-14.
 
Evidence that recurrent Plasmodium falciparum infection is caused by recrudescence of resistant parasites
Al-Yaman F., Genton B., Reeder J. C., Anders R. F., Alpers M. P., 1997/04. American Journal of Tropical Medicine and Hygiène, 56 (4) pp. 436-9.
 
Humoral response to defined Plasmodium falciparum antigens in cerebral and uncomplicated malaria and their relationship to parasite genotype
Al-Yaman F., Genton B., Reeder J. C., Mokela D., Anders R. F., Alpers M. P., 1997/04. American Journal of Tropical Medicine and Hygiène, 56 (4) pp. 430-5.
 
A Couple with Simultaneous Fevers due to Falciparum and Vivax Malaria
Genton B., Dickson R., Alpers M. P., 1996/12. Journal of Travel Medicine, 3 (4) pp. 235-236.
 
Rapid Manual Diagnosis of Plasmodium falciparum Malaria Using ParaSight-F Dipsticks Applied to Human Blood and Urine
Genton B., Hii J., Paget S., Alpers M. P., 1996/09. Journal of Travel Medicine, 3 (3) pp. 172-173.
 
Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea
Reeder J. C., Rieckmann K. H., Genton B., Lorry K., Wines B., Cowman A. F., 1996/08. American Journal of Tropical Medicine and Hygiène, 55 (2) pp. 209-13.
 
Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea
Al Yaman F. M., Mokela D., Genton B., Rockett K. A., Alpers M. P., Clark I. A., 1996/06. Transactions of the Royal Society of Tropical Medicine and Hygiène, 90 (3) pp. 270-3.
 
Occurrence of the erythrocyte band 3 (AE1) gene deletion in relation to malaria endemicity in Papua New Guinea
Mgone C. S., Koki G., Paniu M. M., Kono J., Bhatia K. K., Genton B., Alexander N. D., Alpers M. P., 1996/06. Transactions of the Royal Society of Tropical Medicine and Hygiène, 90 (3) pp. 228-31.
 
Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity
al-Yaman F., Genton B., Kramer K. J., Chang S. P., Hui G. S., Baisor M., Alpers M. P., 1996/05. American Journal of Tropical Medicine and Hygiène, 54 (5) pp. 443-8.
 
Resistance of Plasmodium falciparum malaria to amodiaquine, chloroquine and quinine in the Madang Province of Papua New Guinea, 1990-1993
al-Yaman F., Genton B., Mokela D., Narara A., Raiko A., Alpers M. P., 1996/03. Papua New Guinea Medical Journal, 39 (1) pp. 16-22.
 
Malaria vaccine in children under 12 months of age
Allen S., Genton B., Alexander N., Gibson N., Raiko A., 1995/12. Lancet, 346 (8989) pp. 1555-6.
 
Ovalocytosis and cerebral malaria
Genton B., al-Yaman F., Mgone C. S., Alexander N., Paniu M. M., Alpers M. P., Mokela D., 1995/12. Nature, 378 (6557) pp. 564-5.
 
Acquired antibody levels to Plasmodium falciparum merozoite surface antigen 1 in residents of a highly endemic area of Papua New Guinea
al-Yaman F., Genton B., Kramer K. J., Taraika J., Chang S. P., Hui G. S., Alpers M. P., 1995/10. Transactions of the Royal Society of Tropical Medicine and Hygiène, 89 (5) pp. 555-9.
 
Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria
al-Yaman F., Genton B., Anders R., Taraika J., Ginny M., Mellor S., Alpers M. P., 1995/09. Parasite Immunology, 17 (9) pp. 493-501.
 
Evidence of HLA class II association with antibody response against the malaria vaccine SPF66 in a naturally exposed population
Beck H. P., Felger I., Barker M., Bugawan T., Genton B., Alexander N., Jazwinska E., Erlich H., Alpers M., 1995/09. American Journal of Tropical Medicine and Hygiène, 53 (3) pp. 284-8.
 
Plasmodium falciparum: malaria morbidity is associated with specific merozoite surface antigen 2 genotypes
Engelbrecht F., Felger I., Genton B., Alpers M., Beck H. P., 1995/08. Experimental Parasitology, 81 (1) pp. 90-6.
 
The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. I. Malariometric indices and immunity
Genton B., al-Yaman F., Beck H. P., Hii J., Mellor S., Narara A., Gibson N., Smith T., Alpers M. P., 1995/08. Annals of Tropical Medicine and Parasitology, 89 (4) pp. 359-76.
 
The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. II. Mortality and morbidity
Genton B., al-Yaman F., Beck H. P., Hii J., Mellor S., Rare L., Ginny M., Smith T., Alpers M. P., 1995/08. Annals of Tropical Medicine and Parasitology, 89 (4) pp. 377-90.
 
Assessment of malaria morbidity in vaccine efficacy trials
Genton B., al-Yaman F., Alpers M. P., 1995/03. Lancet, 345 (8952) p. 804.
 
The use of the polymerase chain reaction for more sensitive detection of Plasmodium falciparum
Felger I., Tavul L., Narara A., Genton B., Alpers M., Beck H. P., 1995/03. Papua New Guinea Medical Journal, 38 (1) pp. 52-6.
 
Human cerebral malaria: lack of significant association between erythrocyte rosetting and disease severity
al-Yaman F., Genton B., Mokela D., Raiko A., Kati S., Rogerson S., Reeder J., Alpers M., 1995/02. Transactions of the Royal Society of Tropical Medicine and Hygiène, 89 (1) pp. 55-8.
 
Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria
Beck H. P., Felger I., Genton B., Alexander N., al-Yaman F., Anders R. F., Alpers M., 1995/02. Infection and Immunity, 63 (2) pp. 596-600.
 
Humoral response to Plasmodium falciparum ring-infected erythrocyte surface antigen in a highly endemic area of Papua New Guinea
al-Yaman F., Genton B., Falk M., Anders R. F., Lewis D., Hii J., Beck H. P., Alpers M. P., 1995/01. American Journal of Tropical Medicine and Hygiène, 52 (1) pp. 66-71.
 
Relationships between Plasmodium falciparum infection and morbidity in a highly endemic area
Smith T., Genton B., Baea K., Gibson N., Taime J., Narara A., Al-Yaman F., Beck H. P., Hii J., Alpers M., 1994/12. Parasitology, 109 ( Pt 5) pp. 539-49.
 
Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea
al-Yaman F., Genton B., Anders R. F., Falk M., Triglia T., Lewis D., Hii J., Beck H. P., Alpers M. P., 1994/11. American Journal of Tropical Medicine and Hygiène, 51 (5) pp. 593-602.
 
Malaria: how useful are clinical criteria for improving the diagnosis in a highly endemic area?
Genton B., Smith T., Baea K., Narara A., al-Yaman F., Beck H. P., Hii J., Alpers M., 1994/10. Transactions of the Royal Society of Tropical Medicine and Hygiène, 88 (5) pp. 537-41.
 
Assessment of the humoral and cell-mediated immunity against the Plasmodium falciparum vaccine candidates circumsporozoite protein and SPf66 in adults living in highly endemic malarious areas of Papua New Guinea
Beck H. P., Felger I., Kabintik S., Tavul L., Genton B., Alexander N., Bhatia K. K., al-Yaman F., Hii J., Alpers M., 1994/09. American Journal of Tropical Medicine and Hygiène, 51 (3) pp. 356-64.
 
Plasmodium falciparum: extensive polymorphism in merozoite surface antigen 2 alleles in an area with endemic malaria in Papua New Guinea
Felger I., Tavul L., Kabintik S., Marshall V., Genton B., Alpers M., Beck H. P., 1994/09. Experimental Parasitology, 79 (2) pp. 106-16.
 
The use of untreated bednets and malaria infection, morbidity and immunity
Genton B., Hii J., al-Yaman F., Paru R., Beck H. P., Ginny M., Dagoro H., Lewis D., Alpers M. P., 1994/06. Annals of Tropical Medicine and Parasitology, 88 (3) pp. 263-70.
 
Malaria vaccine: the end of the tunnel?
Genton B., 1994/03. Papua and New Guinea medical journal, 37 (1) pp. 1-2.
 
Resistance of Plasmodium falciparum in vivo to 3 days' treatment with quinine and single-dose Fansidar
Al-Yaman F., Genton B., Mokela D., Alpers M. P., 1994/03. Papua New Guinea Medical Journal, 37 (1) pp. 54-6.
 
Specialized Travel Consultation Part I: Travelers' Prior Knowledge
Genton B., Behrens R. H., 1994/03. Journal of Travel Medicine, 1 (1) pp. 8-12.
 
Specialized Travel Consultation Part II: Acquiring Knowledge
Genton B., Behrens R. H., 1994/03. Journal of Travel Medicine, 1 (1) pp. 13-15.
 
Cerebrospinal fluid lactate in 78 cases of adult meningitis
Genton B., Berger J. P., 1990. Intensive Care Medicine, 16 (3) pp. 196-200.
 
Controle medical au retour des voyages exotiques: quel bilan et pour qui? [Medical evaluation of travelers returning from the tropics: which diagnostic studies and for whom?]
Raeber P. A., Genton B., Darioli R., 1989/06. Schweizerische Rundschau fur Medizin Praxis, 78 (25) pp. 710-4.
 
Les meningites de l'adulte au Centre hospitalier universitaire vaudois. Diagnostic, prise en charge et evolution de 112 cas. [Meningitis in adults at the Vaudois University Hospital Center. Diagnosis, management and development of 112 cases]
Genton B., Berger J. P., 1988/09. Revue Médicale de la Suisse Romande, 108 (9) pp. 795-803.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University